• Investing
  • Stock
  • Economy
  • Editor’s Pick
Portfolio Performance Today
Economy

Legal group sues FDA over puberty blocker records, citing alleged Biden-era cover-up

by August 30, 2025
by August 30, 2025

America First Legal (AFL) sued the Food and Drug Administration on Friday to obtain Biden-era records related to the government’s internal guidance for the recommended use of puberty blockers for kids.  

The Trump-aligned legal group previously uncovered communications from the former administration through a Freedom of Information Act (FOIA) request, which reportedly showed the FDA knew that these drugs increased mental health risk but still recommended approving them for kids.

Following those uncovered communications, AFL followed up with a separate FOIA requesting documents specifically pertaining to the FDA’s internal guidance for the off-label use of these drugs. Despite acknowledging the federal information request, the FDA has not cooperated, and the deadline to produce documents is up.

 

‘The Biden administration pushed gender-denying treatments on American kids. Now, it’s time to expose what officials really knew,’ AFL counsel Will Scolinos, said. 

Similar to AFL’s current FOIA request, the group was required to engage in litigation to compel the release of the first set of documents. 

But, eventually, documents were released that seemed to show the Biden-era Division of General Endocrinology at the FDA recommended the agency approve puberty blockers for children despite the knowledge that there were negative impacts associated with them, such as increased depression, suicidality and seizure risks.

‘There is definitely a need for these drugs to be approved for gender transition,’ an FDA official from the agency’s endocrinology division stated in an email uncovered by AFL. In the same communications, the FDA official also explicitly states that studies found ‘increased risk of depression and suicidality, as well as increased seizure risk.’

Such findings have been confirmed by other studies as well.

Researchers at the University of Texas sampled 107,583 patients 18 and older who had gender dysphoria, including some who underwent gender surgery, and concluded that ‘gender-sensitive mental health support … to address post-surgical psychological risks’ is a ‘necessity.’

 

Males who received surgery had depression rates of 25% compared to males without surgery, who had rates slightly below 12%. Anxiety rates among that group were 12.8% compared to 2.6%.

The same differences were seen among females as well. Those with surgery had 22.9% depression rates compared to 14.6% in the non-surgical group. Females who did get surgery also had a rate of anxiety of 10.5% compared to 7.1% for girls who had not gotten surgery.

Fox News Digital reached out to the FDA for comment but did not immediately receive a response. 

Fox News’ Melissa Rudy and Michael Dorgan contributed to this report

This post appeared first on FOX NEWS

0 comment
0
FacebookTwitterPinterestEmail

previous post
Are We Doomed to Repeat Economic History, Even When We Know It?
next post
House investigators nix Mueller testimony in Epstein probe over health concerns

Related Posts

Tariffs Rest on Distrust of Citizens

October 3, 2025

What I Saw in Milei’s Argentina

October 3, 2025

White House says federal layoffs could hit ‘thousands’...

October 3, 2025

Democrats refuse to budge over Obamacare fight as...

October 3, 2025

Johnson shuts door on negotiating shutdown deal as...

October 3, 2025

‘Real consequences’: Food aid, flood insurance, FEMA funds...

October 3, 2025

Trump must triple severely outdated nuke arsenal to...

October 3, 2025

FLASHBACK: James Comey urged officials to always prosecute...

October 3, 2025

The agency staff Vought might recommend cutting and...

October 3, 2025

Trump’s DOGE savings dwarfed by Medicare, Social Security...

October 3, 2025

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

Recent Posts

  • What I Saw in Milei’s Argentina

    October 3, 2025
  • Tariffs Rest on Distrust of Citizens

    October 3, 2025
  • Cyberattack halts Asahi production, disrupts Japan’s beer supply

    October 3, 2025
  • Europe markets open: Stoxx 600 rises 0.4%, extending its record-setting rally

    October 3, 2025
  • Bitcoin ETFs see over $600M in inflows as BTC price nears $120K

    October 3, 2025
  • Stockholm leads Europe in IPO activity with $6.8 billion raised

    October 3, 2025

Editors’ Picks

  • 1

    Meta executives eligible for 200% salary bonus under new pay structure

    February 21, 2025
  • 2

    Walmart earnings preview: What to expect before Thursday’s opening bell

    February 20, 2025
  • 3

    New FBI leader Kash Patel tapped to run ATF as acting director

    February 23, 2025
  • 4

    Cramer reveals a sub-sector of technology that can withstand Trump tariffs

    March 1, 2025
  • 5

    Anthropic’s newly released Claude 3.7 Sonnet can ‘think’ as long as the user wants before giving an answer

    February 25, 2025
  • 6

    Nvidia’s investment in SoundHound wasn’t all that significant after all

    March 1, 2025
  • 7

    Pop Mart reports 188% profit surge, plans aggressive global expansion

    March 26, 2025

Categories

  • Economy (2,770)
  • Editor's Pick (279)
  • Investing (185)
  • Stock (1,885)
  • About us
  • Contact us
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 Portfolioperformancetoday.com All Rights Reserved.

Portfolio Performance Today
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
Portfolio Performance Today
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
Copyright © 2025 Portfolioperformancetoday.com All Rights Reserved.

Read alsox

President Trump reveals what he told Zelenskyy...

May 1, 2025

Meta on Trial—But Free Enterprise Is the...

July 9, 2025

The Great COVID Exodus: How the Pandemic...

April 15, 2025